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The CNGB1 gene encodes a protein involved in both photoreceptor and olfactory signal transduction. 
Patients with retinitis pigmentosa (RP) due to bi-allelic variants in this gene were previously reported to 
describe no olfactory problems.1,2 A subsequent quantitative study found objectively reduced olfactory 
function in 8 of 9 patients tested (89%), with 3 patients (33%) aware of their olfactory impairment.3 Variants 
can occur in the N-terminal glutamic acid-rich protein (GARP) domain or in the channel domain. The GARP 
domain is important in rod photoreceptors, but its role in olfactory neurons is less clear; an alternatively 
spliced variant (CNGB1b), lacking this domain, is expressed in olfactory neurons in rats.4 We investigated 
awareness of olfactory problems in our molecularly characterised cohort, and explored in which domain 
variants occurred. 
 
The electronic inherited retinal disease database of Moorfields Eye Hospital was searched for patients with a 
molecularly confirmed diagnosis of CNGB1-associated RP. Patients were asked (by telephone or during clinic 
visits) whether they were aware of problems with their sense of smell. Disease-causing variants were 
classified by occurrence within the GARP or channel domain of the protein. It was hypothesised that patients 
with both variants in the channel domain might be more likely to be aware of olfactory impairment (as a 
GARP domain change would not affect translation of a splice variant that lacked this domain). 
 
Nineteen affected patients (mean (SD) age 60 (11) years; 11 females) from 18 families were identified. 
Fifteen patients (79%) were successfully contacted (mean (SD) age 61 (11) years; 9 females). Of these, six 
(40%) reported reduced or absent sense of smell; the remainder reported no problems. Mean age and sex 
distribution did not differ between those with or without awareness of olfactory impairment. Table 1 
summarises patient characteristics, including causative variants, and their responses. The majority of 
variants have been previously reported.3,5 The novel variants all had a frequency in the gnomAD database of 
less than 0.0002 and were predicted to be disease-causing. 
 
Seven out of the 15 patients had both disease-causing variants occurring in the channel domain. Of these, 5 
reported reduced or absent sense of smell. Of the 8 remaining patients (who had at least one disease-
causing variant in the GARP domain), only one was aware of a reduced sense of smell. The difference in 
proportions was significant (p=0.04, Fisher exact test, two-tailed). If combined with the subjective reports of 
olfactory impairment in the previous study of 9 patients (only one of whom had a variant in the GARP 
domain),3 the difference in proportions remained significant (p=0.03). 
 
Our findings confirm that a substantial proportion of patients with CNGB1-associated RP report reduced or 
absent sense of smell when specifically questioned. In our cohort, patients with at least one variant in the 
GARP domain were less likely to report olfactory impairment, suggesting that this domain might be less 
important in olfaction than in photoreceptor function. Limitations of our study include reliance on subjective 
awareness of olfactory impairment; it is possible that objective quantitative assessment of olfaction would 
reveal more individuals with hyposmia. RP has hundreds of associated genes; awareness of specific non-
ocular features associated with certain genotypes can assist in guiding gene testing or its interpretation. 
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Table 1. Demographics, molecular changes and subjective perceived impairment in sense of smell for the 
patients included in the present study. Patients 14 and 15 are siblings. The transcript ID for variant 
annotation is NM_001297.4. The following variants have not been previously reported in the context of 
CNGB1-associated retinitis pigmentosa (frequency in the gnomAD database, 
https://gnomad.broadinstitute.org, accessed 6 May 2019, of each allele is also given): p.(Gln116*), 4.02x10-6; 
p(.Glu577Serfs*6), not found in gnomAD; p.(Arg762His), 1.61x10-5; p.(Gly847Glu), 8.01x10-6; p.(Tyr892*), not 
found in gnomAD; p.(Glu994*), not found in gnomAD. All were predicted to be disease causing 
(http://www.mutationtaster.org/, accessed 6 May 2019). c.534+1G>A affects a splice donor site, and has a 










sense of smell Base change Effect Base change Effect 
1 50 M c.2777-?_2958+?del (Exon 28-29 deletion) p.? 
c.2777-?_2958+?del 
(Exon 28-29 deletion) p.? Yes Absent 
2 45 F c.2957A>T p.(Asn986Ile) c.2957A>T p.(Asn986Ile) Yes Normal 
3 68 M c.2285G>A p.(Arg762His) c.2285G>A p.(Arg762His) Yes Normal 
4 53 F c.2544dupG p.(Leu849Alafs*3) c.2544dupG p.(Leu849Alafs*3) Yes Reduced 
5 64 F c.2957A>T p.(Asn986Ile) c.2544dupG p.(Leu849Alafs*3) Yes Reduced 
6 56 M c.1729delG p.(Glu577Serfs*6) c.1729delG p.(Glu577Serfs*6) Yes Reduced 
7 71 F c.2676C>A p.(Tyr892*) c.2980G>T p.(Glu994*) Yes Reduced 
8 68 F c.2957A>T p.(Asn986Ile) c.534+1G>A Splice defect No Normal 
9 42 M c.2544dupG p.(Leu849Alafs*3) c.262C>T p.(Gln88*) No Normal 
10 82 M c.2540G>A p.(Gly847Glu) c.346C>T p.(Gln116*) No Normal 
11 59 F c.262C>T p.(Gln88*) c.664C>T p.(Gln222*) No Normal 
12 67 F c.2258T>A p.(Leu753*) c.807G>C p.(Gln269His) No Normal 
13 63 F c.413-1G>A Splice defect c.413-1G>A Splice defect No  Absent 
14 69 F c.952C>T p.(Gln318*) c.2957A>T p.(Asn986Ile) No Normal 
15 64 M c.952C>T p.(Gln318*) c.2957A>T p.(Asn986Ile) No Normal 
 
 
